The Pulmonary Fibrosis Foundation (PFF) is now accepting applications for a new program, called PFF Scholars, that aims to…
Articles by Diogo Pinto
Samumed and United Therapeutics announced an exclusive license agreement for North American rights to Samumed’s investigational therapy…
A research team from the University of Arizona (UA) College of Medicine – Tucson was given a $4.4 million…
Surgery for lung cancer should be carefully considered in patients who also have idiopathic pulmonary fibrosis (IPF), because it is…
The Pulmonary Fibrosis Foundation (PFF) has completed the enrollment of PF patients in its PFF Patient Registry, with the admission…
Pliant Therapeutics raised $62 million in a second round of financing that will be used to support the development…
A man with idiopathic pulmonary fibrosis (IPF) was kept alive and his blood oxygenated for more than a year while waiting for…
Formaldehyde, a chemical widely used in construction, health, and manufacturing industries, was seen to worsen lung inflammation and fibrosis in…
A new, wireless home monitoring program designed to collect data on lung function from patients with idiopathic pulmonary fibrosis (IPF)…
People close to idiopathic pulmonary fibrosis (IPF) patients and those they interact with — from family members and acquaintances…